Workflow
公司上市
icon
Search documents
王兴投资了王兴兴:美团合计持有宇树科技9.65%股份,位列第二大股东
Xin Lang Cai Jing· 2026-03-22 07:45
Core Viewpoint - Yushu Technology has officially submitted its IPO application to the Shanghai Stock Exchange, aiming to raise 4.2 billion yuan [1] Shareholder Structure - The founder, Wang Xingxing, holds 23.82% of the shares, but through special voting rights, he controls 68.78% of the voting power, indicating strong control over the company [1] - Meituan is the second-largest shareholder, holding a total of 9.6488% through various companies, showcasing its significant influence in the industry [3][7] - Sequoia China ranks third with a shareholding of 7.1149% [4][8] - Matrix Partners holds 5.4528% of the shares, making it the fourth-largest shareholder [5][9] - Other notable investors include Lei Jun's Shunwei Capital with 4.4245% and Tencent with 0.5986% [5][9] Market Position - The presence of major internet giants and top-tier venture capitalists in Yushu Technology's IPO indicates strong market interest and recognition within the capital circle [6][9]
OpenAI:将在合适时机考虑上市
Ge Long Hui A P P· 2026-02-27 14:06
Core Viewpoint - OpenAI's founder, Sam Altman, indicated that the company will consider going public at the appropriate time [1] Group 1 - OpenAI is exploring the possibility of an IPO, signaling potential growth and maturity in the company [1]
字节首个子公司或独立上市
Xin Lang Cai Jing· 2026-02-27 10:36
Group 1 - ByteDance's automotive platform, Dongchedi, plans to go public in Hong Kong with an expected fundraising of $1-1.5 billion [1] - After being spun off from the group in 2023, Dongchedi secured $600 million in financing from investors including General Atlantic and Sequoia China in 2024, achieving a valuation of $3 billion [1] - Dongchedi, originally the automotive channel of Toutiao, has been operating independently since 2017 and currently competes with platforms like Autohome and Yiche [1]
立讯精密工业股份有限公司(H0438) - 整体协调人公告-委任
2026-02-26 16:00
香港聯合交易所有限公司及證券及期貨事務監察委員會對本公告的內容概不負責,對其準確 性或完整性亦不發表任何聲明,並表明概不就因本公告全部或任何部分內容而產生或依賴該 等內容而引致的任何損失承擔任何責任。 Luxshare Precision Industry Co., Ltd. 立訊精密工業股份有限公司 (於中華人民共和國註冊成立的股份有限公司) 警 告 本公告根據香港聯合交易所有限公司(「聯交所」)及證券及期貨事務監察委員 會(「證監會」)的要求而刊發,僅用作向香港公眾人士提供資料。您閱覽本公告, 即表示您知悉、接納並向立訊精密工業股份有限公司(「本公司」)、其聯席保薦 人、整體協調人、顧問或包銷團成員表示同意: – 2 – (e) 本公告(及其所載資料)僅供參考,並不構成或組成於美國(包括其領土及 屬地、美國任何州及哥倫比亞特區)或發售或出售將屬違法的任何其他司 法權區提呈發行或出售或招攬購買、認購或以其他方式收購本公司任何 證券的任何要約的一部分。本公司認為其為「外國私人發行人」(「外國私 人發行人」,定義見1933年美國證券法(經修訂)(「美國證券法」)第405條), 並擬盡可能經營其業務以維持其作為外 ...
Zaihui Inc.(H0419) - 整体协调人公告-委任
2026-02-12 16:00
香港聯合交易所有限公司及證券及期貨事務監察委員會對本公告的內容概不負責,對其準確性或完整性亦不發表 任何聲明,並明確表示概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何 責任。 Zaihui Inc. (於開曼群島註冊成立的有限公司) 警 告 本公告並不構成向任何司法管轄區的公眾人士提呈出售任何證券的招股章程、發售通函、通告、通函、小冊子或 廣告,亦不構成出售要約或邀請公眾人士以誘導或招攬收購、購買或認購證券的要約,且並非旨在邀請公眾人士 提出認購或購買任何證券的要約。本公告不應被視為勸誘認購或購買任何證券,亦不擬構成該等勸誘。本公告僅 為提供有關Zaihui Inc.(「本公司」)資料而刊發,除此之外概無任何其他用途。任何投資決定一概不應根據本公告所 載資料而作出。概不保證發售將會進行;任何證券發售均需要最終上市文件,而此乃投資者於作出投資決定時唯 一應依賴的文件。並無跡象顯示本公告所涉及的上市申請已獲批准。 本公告乃根據香港聯合交易所有限公司(「聯交所」)及證券及期貨事務監察委員會(「證 監會」)的要求而刊發,僅用作向香港公眾人士提供資料。 閣下閱覽本公告,即表示 閣下知悉、 ...
财务负责人、董秘全部换人,山西建投旗下这家新三板公司上市进程或迎加速
Sou Hu Cai Jing· 2026-02-10 01:27
Core Viewpoint - Shan'an Lantian has appointed Wang Jing as the new financial officer and board secretary, which is seen as a strategic move to facilitate the company's goal of listing on the main board within three years [1][2]. Group 1: Management Changes - Wang Jing has been appointed as the financial officer and board secretary, effective February 9, 2026, while Zhang Yanhua and Ji Yanfei have been relieved of their respective positions [2]. - Wang Jing has extensive experience in financial management and investor relations, having worked at Shanxi Installation for several years [3][10]. Group 2: Company Background - Shan'an Lantian is the first company in the Shanxi construction industry to be listed on the New Third Board and aims for a main board listing [2][5]. - The company focuses on energy-saving services in the centralized heating sector, engaging in investment, design, construction, and operation of energy-saving projects [3]. Group 3: Financial Performance - In 2024, Shan'an Lantian achieved a revenue of 487 million yuan, representing a year-on-year growth of 8.88%, and a net profit attributable to shareholders of 117 million yuan, up by 6.80% [8]. Group 4: Governance Improvements - The company has made several governance structure optimizations, including the dissolution of the supervisory board and the establishment of an audit committee, which are expected to support its capital market ambitions [10].
天津阿童木机器人股份有限公司(H0369) - 整体协调人公告-委任(经修订)
2026-02-09 16:00
(a) 在聯交所網站登載本公告並不引起本公司、其獨家保薦人、整體協調人、顧 問或包銷團成員須在香港或任何其他司法權區進行發售或配售的任何責任。 本公司會否進行發售或配售仍屬未知之數; (b) 本公告所涉及的上市申請尚未獲批准,聯交所及證監會或會接納、發回或拒 絕有關的公開發售及╱或上市申請; (c) 本公告不應被視為勸誘認購或購買任何證券,亦不擬構成該等勸誘; (d) 本公司或本公司的任何聯屬公司、顧問或包銷團成員概無於任何司法權區透 過刊發本公告而發售任何證券或招攬投資者提出認購或購買任何證券的要 約; 香港聯合交易所有限公司及證券及期貨事務監察委員會對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何部分內容而產生或依賴該 等內容而引致的任何損失承擔任何責任。 Tianjin Atomrobot Co., Ltd. 天津阿童木機器人股份有限公司 (於中華人民共和國註冊成立的股份有限公司) 警告 本公告乃根據香港聯合交易所有限公司(「聯交所」)及證券及期貨事務監察委員 會(「證監會」)的要求而刊發,僅用作向香港公眾人士提供資料。 閣下閱覽本公 告,即代表 閣下知悉 ...
君乐宝创始人及核心团队在上市前大额增持公司股份 凸显强烈信心
Zheng Quan Ri Bao Wang· 2026-02-05 12:42
Core Viewpoint - Significant changes in the shareholder structure of Junlebao are observed, with new investments from Moutai Group and other notable investment firms, indicating strong confidence from the founder and core team in the company's future development [1] Group 1: Shareholder Changes - By December 2025, Junlebao's shareholder list will include new investors such as Moutai Jinshi (Guizhou) Biotechnology Industry Fund and Qiongcheng Fuman Venture Capital, managed by Jinding Capital [1] - Existing shareholders, including Housheng Capital's Quanzhou Haisi Houjiu Equity Investment Partnership, have increased their stakes in the company [1] Group 2: Founder and Core Team's Stake Increase - The founder Wei Lihua and his core team have increased their holdings from approximately 15.00% to 20.61%, representing a total increase of about 5.61% [1] - The estimated amount for this increase in holdings exceeds 1.1 billion yuan, as all dividends received over the past three years were reinvested into this stake increase [1] Group 3: Market Implications - The substantial increase in holdings by the founder and core team before the company's IPO is seen as a strong signal of confidence in the company's fundamentals and future prospects, potentially reassuring future investors in the Hong Kong stock market [1]
君乐宝创始人及核心团队在上市前大额增持公司股份,突显强烈信心
Jin Rong Jie· 2026-02-05 10:12
Core Insights - Significant changes in the shareholder structure of Junlebao are expected by December 2025, with new investments from Moutai Group and other notable investment firms [1] - The founder, Wei Lihua, has increased his stake through various employee stock ownership platforms, raising his total shareholding from approximately 15.00% to 20.61%, an increase of about 5.61% [1] - The estimated amount for Wei Lihua and the core team's share purchase exceeds 1.1 billion yuan, funded entirely by dividends received over the past three years [1] - The substantial increase in shareholding by the founder and core team before the IPO reflects strong confidence in the company's fundamentals and future development, serving as a positive signal for potential investors in the Hong Kong stock market [1]
可孚医疗:已于2025年8月29日向香港联交所递交H股发行及上市申请
Jin Rong Jie· 2026-02-02 08:30
Core Viewpoint - The company, KeFu Medical, has submitted its application for H-share issuance and listing to the Hong Kong Stock Exchange on August 29, 2025, and is awaiting approval from relevant regulatory bodies [1]. Group 1: Listing Progress - KeFu Medical has officially submitted its H-share issuance and listing application to the Hong Kong Stock Exchange [1]. - The approval process requires consent from the Hong Kong Securities and Futures Commission, the Hong Kong Stock Exchange, and the China Securities Regulatory Commission [1]. Group 2: Market Value Management - The company emphasizes that the core support for market value lies in the quality of its operational development and long-term value creation capabilities [1]. - KeFu Medical plans to focus on its main business development, enhancing R&D innovation, production operations, market expansion, and international layout capabilities [1]. - The company aims to solidify its operational fundamentals and enhance its core competitiveness and sustainable development capacity to create long-term stable investment value for shareholders [1]. Group 3: Communication and Disclosure - KeFu Medical commits to adhering to regulatory requirements for information disclosure and strengthening communication with the capital market [1]. - The company encourages investors to stay updated on its operational developments through future announcements [1].